Besides its physiological functions, CD9 is widely associated with diseases: both the up-regulation and down-regulation of CD9 are linked with poor prognosis in several types of cancer, such as melanoma, leukemia, and gastric, lung, breast, colon, and prostate malignancies (Brosseau et al, 2018). This evidence concerns the gene CD9 and cancer.